Inventor · disambiguated record
Xingxing Zang
Also filed as: ZANG XINGXING
12 granted patents·11 pending applications·17 citations·filing 2007–2024
85Inventor score
Files withALBERT EINSTEIN COLLEGE MEDICINE17ALBERT EINSTEIN COLLEGE MEDICINE INC3ALBERT EINSTEIN COLLEGE MEDICINE YESHIVA UNIV1UNIV ST LOUIS1ZANG XINGXING1
Top patents by PatentIndex Score
23 records- 0187US9447186B2Antibodies to human B7x for treatment of metastatic cancerZANG XINGXING·Filed 2013·Granted Sep 20, 2016·10 cites·15 claims
- 0284US11377494B2Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formulations, kits, and methods of use thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Jul 5, 2022·2 cites·12 claims
- 0381US10093737B2HHLA2 as a novel inhibitor of human immune system and uses thereofALBERT EINSTEIN COLLEGE MEDICINE YESHIVA UNIV·Filed 2014·Granted Oct 9, 2018·3 cites·7 claims
- 0479US11261253B2HHLA2 as a novel inhibitor of human immune system and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Mar 1, 2022·1 cites·10 claims
- 0576US2024270812A1Tmigd2 and its derivatives as blockers or binders of cancer-expressed hhla2 for immunotherapiesALBERT EINSTEIN COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 0675US2023076027A1Hhla2 as a novel inhibitor of human immune system and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0774US10689432B2B7X and its derivatives for treating and preventing cardiovascular diseaseALBERT EINSTEIN COLLEGE MEDICINE·Filed 2014·Granted Jun 23, 2020·1 cites·3 claims
- 0874US2025034248A1Monoclonal antibodies against human tim-3ALBERT EINSTEIN COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 0972US2023002491A1Hhla2 as a novel inhibitor of human immune system and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 1071US12221489B2Antibodies to human B7x for treatment of metastatic cancerALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted Feb 11, 2025·0 cites·13 claims
- 1167US12145989B2Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formulations, kits, and methods of use thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Granted Nov 19, 2024·0 cites·9 claims
- 1264US12134645B2Monoclonal antibodies against human tim-3ALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Nov 5, 2024·0 cites·11 claims
- 1363US10882893B2TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapiesALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Jan 5, 2021·0 cites·6 claims
- 1462US2021388052A1Tmigd2 and its derivatives as blockers or binders of cancer-expressed hhla2 for immunotherapiesALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 1562US2024336917A1Compositions and methods for inhibiting the expression of tmigd2ALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 1661US2008269464A1Compositions and methods for modulating lymphocte activityUNIV ST LOUIS·Filed 2007·Application pending·0 cites
- 1758US2017029525A1Antibodies to human b7x for treatment of metastatic cancerALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2016·Application pending·0 cites
- 1856US12263203B2BTNL9 and ERMAP as novel inhibitors of the immune system for immunotherapiesALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted Apr 1, 2025·0 cites·15 claims
- 1952US10280208B2TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapiesALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2015·Granted May 7, 2019·0 cites·14 claims
- 2052US2025019435A1Methods, compositions, and kits for modifying immune cell activity via kir2dl5ALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 2151US2025320269A1Chimeric antigen receptors targeting b7-h3 (cd276) and associated methodsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 2248US12252538B2Monoclonal antibodies against IgV domain of B7-H3 and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Mar 18, 2025·0 cites·13 claims
- 2341US2018296636A1Btnl9 and ermap as novel inhibitors of the immune system for immunotherapiesALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xingxing Zang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →